An electrical power system includes a switched reluctance machine/inverter adapted for providing DC power to a load; a voltage controller, which provides a control angle θCto the switched reluctance machine/inverter; an extraction module having an interface to the DC power and providing a resonant f
An electrical power system includes a switched reluctance machine/inverter adapted for providing DC power to a load; a voltage controller, which provides a control angle θCto the switched reluctance machine/inverter; an extraction module having an interface to the DC power and providing a resonant frequency content in Park vector format of a resonant frequency content at the interface; a phase locked loop, which provides a transformation angle θ from the resonant frequency content in Park vector format; a resonant frequency voltage controller, which uses the resonant frequency content in Park vector format and the transformation angle θ to provide a control angle Δθ to the switched reluctance machine/inverter so that the control angle θCand the control angle Δθ can be used to regulate the DC power and the resonant frequency content is attenuated in regulating the DC power.
대표청구항▼
An electrical power system includes a switched reluctance machine/inverter adapted for providing DC power to a load; a voltage controller, which provides a control angle θCto the switched reluctance machine/inverter; an extraction module having an interface to the DC power and providing a resonant f
An electrical power system includes a switched reluctance machine/inverter adapted for providing DC power to a load; a voltage controller, which provides a control angle θCto the switched reluctance machine/inverter; an extraction module having an interface to the DC power and providing a resonant frequency content in Park vector format of a resonant frequency content at the interface; a phase locked loop, which provides a transformation angle θ from the resonant frequency content in Park vector format; a resonant frequency voltage controller, which uses the resonant frequency content in Park vector format and the transformation angle θ to provide a control angle Δθ to the switched reluctance machine/inverter so that the control angle θCand the control angle Δθ can be used to regulate the DC power and the resonant frequency content is attenuated in regulating the DC power. id surface of said film; a first agarose gelcoat layer overlying said first biologically active ligand, said agarose layer being permeable to the toxic substance and containing at least one ingredient to enhance the growth thereof, said layer further containing a detector antibody which is a biologically active ligand characterized by its ability to recognize a secondary epitope of said particular toxic substance, thereby forming a detector antibody/antigen complex; and a second protective gelcoat layer overlying the detector antibody and having a degree of porosity whereby passage of said toxic substance is permitted and passage of said detector antibody/antigen complex is prevented, said second protective gelcoat layer having a degree of abrasion resistance effective to protect the biological assay material; wherein said first biologically active ligand includes at least one antibody having dual specificity for a primary epitope and a secondary epitope. 2. The biological assay material according to claim 1 wherein the flexible film is a polyolefin selected from the group consisting of polyethylene, polypropylene and mixtures thereof. 3. The biological assay material according to claim 1 wherein the flexible film is a polyvinylchloride. 4. The biological assay material according to claim 1 wherein the particular toxic substance is one or more members selected from the group consisting of a particular microorganism, biological materials containing the genetic characteristics of said particular microorganism, and any mutations thereof. 5. The biological assay material according to claim 1 wherein the particular toxic substance is selected from the group consisting of microorganisms, nucleic acids, proteins, integral components of microorganisms and combinations thereof. 6. The biological assay material according to claim 1 wherein the first biologically active ligand is selected from the group consisting of an antibody, a single stranded nucleic acid probe, an aptamer, a lipid, a natural receptor, a lectin, a carbohydrate and a protein. 7. The biological assay material according to claim 1 further including a scavenger antibody which is a biologically active ligand characterized as having a higher affinity for the particular toxic substance than the first biologically active ligand, said scavenger antibody being included within said first agarose gelcoat layer in a sufficient amount to bind with the particular toxic substance up to and including a specific threshold concentration; whereby said first biologically active ligand will be prevented from binding with a detector antibody until the concentration of the particular toxic substance surpasses the specific threshold concentration. 8. A material useful for food packaging and characterized by its ability to detect the presence and particularly identify one or more toxic substances comprising: a base layer which is a flexible film for immobilization of a ligand applied to a surface thereof and wherein said film is selected from the group consisting of a polyolefin and a polyvinylchloride; a first biologically active ligand characterized by its ability to recognize one or more epitopes of particular toxic substances, said ligand being immobilized onto said surface of said flexible film; a first protective agarose gelcoat layer overlying the first biologically active ligand, said agarose layer being permeable to the toxic substance; a detector antibody which is a second biologically active ligand characterized by its ability to recognize different epitopes of said particular toxic substances, said detector antibody overlying said first protective gelcoat layer and in juxtaposed relation thereto; and a second gelcoat layer overlying the detector antibody and having a degree of porosity sufficient to prevent passage of said detector antibody therethrough. 9. The material according to claim 8 wherein the flexible polyolefin film is selected from the group consist ing of polyethylene, polypropylene and mixtures thereof. 10. The material according to claim 8 wherein the flexible film is a polyvinylchloride. 11. The material according to claim 8 wherein the particular toxic substance is one or more members selected from the group consisting of one or more gram negative and gram positive microorganisms and species thereof, biological materials containing the genetic characteristics of said particular microorganisms, and any mutations thereof. 12. The material according to claim 8 wherein said particular toxic substance is selected from the group consisting of microorganisms, nucleic acids, proteins, integral components of microorganisms and combinations thereof. 13. The material according to claim 8 wherein the first biologically active ligand is selected from the group consisting of an antibody, a single stranded nucleic acid probe, an aptamer, a lipid, a natural receptor, a lectin, a carbohydrate and a protein. 14. The material according to claim 8 further including a scavenger antibody which is a biologically active ligand characterized as having a higher affinity for the particular toxic substance than the capture antibody, said scavenger antibody being included within said first agarose gelcoat layer in a sufficient amount to bind with the particular toxic substance up to and including a specific threshold concentration; whereby said first biologically active ligand will be prevented from binding with a detector antibody until the concentration of the particular toxic substance surpasses the specific threshold concentration. 15. The material according to claim 8 wherein one or more species of first biologically active ligand are immobilized onto said surface of said flexible film in a particular orientation, each of said one or more species being characterized by a unique shape; and one or more corresponding species of detector antibody are applied onto the surface of said first protective gelcoat layer in the same particular orientation as said one or more species of first biologically active ligand, each of said one or more species being characterized by a corresponding unique shape; whereby simultaneous binding of any of the one or more species of first biologically active ligands and one or more corresponding species of detector antibodies with the particular toxic substance which they recognize results in the appearance of a visual signal having the unique shape assigned to that species; wherein an observer is alerted to the presence and identity of said particular toxic substance. of less than 1000 cps. 2. The wipe product according to claim 1, wherein the nonionic surfactant is a mixture of (i) a polyoxyethylene-polyoxypropylene block polymer and (ii) a mixture of laurate esters of sorbitol and sorbital anhydrides condensed with 20 moles of ethylene oxide. 3. The wipe product according to claim 1, comprising (a) from about 0.05 to about 2.00% by weight of said acrylate/C10-C30alkyl acrylate cross polymer emulsifier; (b) from about 0.05 to about 0.50% by weight said salicylic acid; and (c) from about 0.1 to about 10% by weight of said nonionic surfactant. 4. The wipe product according to claim 2, comprising (a) from about 0.12 to about 0.13% by weight of of said acrylate/C10-C30alkyl acrylate cross polymer emulsifier; (b) from about 0.05 to about 0.50% by weight said salicylic acid; and (c) from about 0.03 to about 0.08% by weight of a polyoxyethylene-polyoxypropylene block polymer and from about 0.03 to about 0.08% of a mixture of laurate esters of sorbitol and sorbital anhydrides condensed with 20 moles of ethylene oxide. 5. The wipe product according to claim 1, further comprising an effective amount of at least one emollient selected from the group consisting of C12-C15alkyl benzoate; cyclomethicone, dimethicone, and mixtures thereof. 6. The wipe product according to claim 1, further comprising an effective amount of at least one humectant selected from the group consisting of butylene glycol, propylene glycol, ethylene glycol, hexylene glycol, diethylene glycols, triethylene glycols, water soluble polyethylene glycols, water soluble polypropylene glycols, glycerol, polyoxyethylene sorbitol, 1,2,4-butane triol, 1,2,6-hexane triol, sorbitol and mixtures thereof. 7. The wipe product according claim 1, further comprising an effective amount of a preservative selected from the group consisting of phenoxyethanol, methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben, and mixtures thereof. 8. The wipe product according to claim 1, wherein said emulsion has a viscosity of less than about 1000 cps. 9. The wipe product according to claim 1, wherein said emulsion has a pH of from about 4.0 to about 5.5. 10. The wipe product according to claim 1, further comprising an effective amount of at least one anti-irritant. 11. The wipe product according to claim 10, wherein said anti-irritant is allantoin. 12. The wet wipe product according to claim 1, wherein said emulsion is free from ethanol. 13. The wet wipe product according to claim 1, wherein said emulsion comprises less than 5% of a polyol. 14. The wipe product according to claim 1, wherein said emulsion is prepared by cold process emulsification. 15. A method for depositing salicylic acid to mammalian skin comprising topically applying the wipe product according to claim 1 to said skin. 16. The method according to claim 15, further comprising the step of rinsing with water the area of the skin treated. 17. A wet wipe product comprising a substrate and an emulsion, said emulsion comprising: (a) from about 0.05 to about 2.00% by weight of an acrylate/C10-C30alkyl acrylate cross polymer emulsifier; (b) from about 0.05 to about 0.50% by weight salicylic acid; (c) from about 0.01 to about 10% of a polyoxyethylene-polyoxypropylene block polymer; (d) from about 0.01 to about 10% of a mixture of laurate esters of sorbitol and sorbital anhydrides condensed with 20 moles of ethylene oxide; (e) from about 0.05 to about 20% by weight of at least one emollient selected from the group consisting of C12-C15alkyl benzoate; cyclomethicone, dimethicone, and mixtures thereof; and (f) from about 0.5 to about 20% of at least one humectant selected from the group consisting of butylene glycol, propylene glycol, and mixtures thereof. 18. The wipe product according to claim 17, wherein said emulsion has a pH ranging from about 4
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (18)
Dolland Carlisle R. (Torrance CA), Active damper for EMI filter.
Rozman Gregory I. (Rockford IL) Cook Alexander (Rockford IL) Markunas Albert L. (Roscoe IL) Bansal Madan L. (Rockford IL) Tsai Shan-Chin (Rockford IL), Electric power generating system with active damping.
Rozman Gregory I. (6248 Sawgrass Dr. Rockford IL 61111) Cook Alexander (219 Washington St. Rockford IL 61104), VSCF system with reduced DC link ripple.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.